ResearchIn-Press PreviewImmunologyPulmonology
Open Access |
10.1172/jci.insight.189205
1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America
Find articles by Li, H. in: PubMed | Google Scholar
1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America
Find articles by
Edin, M.
in:
PubMed
|
Google Scholar
|
1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America
Find articles by Menendez, D. in: PubMed | Google Scholar
1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America
Find articles by Bradbury, J. in: PubMed | Google Scholar
1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America
Find articles by Graves, J. in: PubMed | Google Scholar
1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America
Find articles by Gruzdev, A. in: PubMed | Google Scholar
1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America
Find articles by
Whitehead, G.
in:
PubMed
|
Google Scholar
|
1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America
Find articles by Sifre, M. in: PubMed | Google Scholar
1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America
Find articles by DeGraff, L. in: PubMed | Google Scholar
1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America
Find articles by Zeldin, D. in: PubMed | Google Scholar
Published September 22, 2026 - More info
Type 2 innate lymphoid cells (ILC2) are a population of lineage-negative cells in the lung, gastrointestinal tract, and skin which have emerged as a significant component of type 2 allergic inflammation. The regulation of cyclooxygenase-2 (COX-2) metabolites is critical to the pathophysiology of many inflammatory disorders, including allergic asthma. While COX-2 regulates Th9 and Th17 cell differentiation and function during allergic lung inflammation, it remains unknown whether COX-2 also regulates ILC2 cell differentiation and function under similar conditions. To address this question, we examined lung ILC2 cells from COX-2+/+ and COX-2-/- mice after ovalbumin (OVA)- or Alternaria-induced allergic lung inflammation. ILC2 cells were significantly increased in COX-2-/- lungs compared with COX-2+/+ lungs after OVA exposure in vivo. The increase in ILC2 cells was accompanied by an increase in expression of the cytokines IL-5 and IL-13, and the transcription factor GATA3. Both genetic disruption and selective inhibition of COX-2 significantly increased ILC2 cell differentiation from isolated common lymphoid progenitor cells (CLP) in vitro. Furthermore, COX-2-derived PGE2 acting via EP2 receptors significantly reduced IL-33 and TSLP expression, and attenuated ILC2 cell differentiation in vitro and in vivo. Thus, during allergic lung inflammation, COX-2-derived PGE2 signals through the EP2 receptor to negatively regulate lung ILC2 cell differentiation and function.